A cohort study examination of established and emerging risk factors for atrial fibrillation: The Busselton Health Study

European Journal of Epidemiology

Volumn 29, Issue 3, 2014, Pages 181-190

  Knuiman, Matthew ^a   Briffa, Tom ^a   Divitini, Mark ^a   Chew, Derek ^b   Eikelboom, John ^c   McQuillan, Brendan ^d   Hung, Joseph ^d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atrial fibrillation; Busselton Health Study; Cohort study; Cox regression; Risk factor

Indexed keywords

ADIPONECTIN; ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; DIABETES MELLITUS; EXERCISE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC SYNDROME X; MIDDLE AGED; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PR INTERVAL; PREDICTOR VARIABLE; QUESTIONNAIRE; RISK ASSESSMENT; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; SMOKING; TRANSIENT ISCHEMIC ATTACK; VALVULAR HEART DISEASE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; AUSTRALIA; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84900305262     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-013-9875-y     Document Type: Article

References (44)

1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82(7):2N-9N. (Pubitemid 28507114)
2. Greenlee RT, Vidaillet H. Recent progress in the epidemiology of atrial fibrillation. Curr Opin Cardiol. 2005;20(1):7-14. (Pubitemid 40030304)
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946-52. (Pubitemid 28446646)
4. Chugh SS, Blackshear JL, Shen W-K, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001;37(2):371-8.
5. Stewart S, Hart CL, Hole DJ, McMurray JJV. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley Study. Am J Med. 2002;113:359-64. (Pubitemid 35223606)
6. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5. doi:10.1001/jama.285.18.2370. (Pubitemid 32424106)
7. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006;114(2):119-25. doi:10.1161/circulationaha.105. 595140. (Pubitemid 44420743)
8. Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119(4):606-18. doi:10.1161/ circulationaha.108.825380.
9. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 1997;96(7):2455-61. (Pubitemid 27425856)
10. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. JAMA. 1994;271(11):840-4. doi:10.1001/jama.1994.03510350050036.
11. Schoonderwoerd BA, Smit MD, Pen L, Van Gelder IC. New risk factors for atrial fibrillation: causes of 'not-so-lone' atrial fibrillation. Europace. 2008;10(6):668-73. doi:10.1093/europace/eun124. (Pubitemid 351775282)
12. Wang TJ, Parise H, Levy D, D'Agostino RB, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA, J Am Med Assoc. 2004;292(20):2471-7. doi:10.1001/ jama.292.20.2471.
13. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Med. 2005;118(5):489.
14. Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166(21):2322-8. doi:10.1001/archinte.166.21.2322. (Pubitemid 44833356)
15. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117(10):1255-60. doi:10.1161/circulationaha.107.744466. (Pubitemid 351365676)
16. Marott SCW, Nordestgaard BG, Zacho J, Friberg J, Jensen GB, Tybjaerg-Hansen A, et al. Does elevated C-reactive protein increase atrial fibrillation risk? A mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol. 2010;56(10):789-95. doi:10.1016/j.jacc. 2010.02.066.
17. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. The Lancet. 2009;373(9665):739.
18. Chamberlain AM, Agarwal SK, Folsom AR, Soliman EZ, Chambless LE, Crow R, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2011;107(1):85-91.
19. Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2): e000102. doi:10.1161/JAHA.112.000102.
20. Knuiman MW, Hung J, Divitini ML, Davis TM, Beilby JP. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study. Eur J Cardiovasc Prevent Rehabil. 2009;16(2): 235-41. doi:10.1097/HJR.0b013e32832955fc.
21. Knuiman MW, James AL, Divitini ML, Bartholomew HC. Correlates of habitual snoring and witnessed apnoeas in Busselton, Western Australia. Aust N Z J Public Health. 2005;29(5):412-5. (Pubitemid 41535944)
22. Beilby J, Divitini ML, Knuiman MW, Rossi E, Hung J. Comparison of cystatin C and creatinine as predictors of cardiovascular events in a community-based elderly population. Clin Chem. 2010;56(5):799-804. doi:10.1373/clinchem.2009.135962.
23. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome-an American Heart Association/National Heart, Lung, and Blood Institute scientific statement-executive summary. Circulation. 2005;112(17):E285-90.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment-insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9. (Pubitemid 15018832)
25. Chambless LE, Diao GQ. Estimation of time-dependent area under the ROC curve for long-term risk prediction. Stat Med. 2006;25(20):3474-86. doi:10.1002/Sim.2299. (Pubitemid 44575164)
26. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-72. doi:10.1002/Sim.2929. (Pubitemid 351193639)
27. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, et al. European ancestry as a risk factor for atrial fibrillation in African Americans. Circulation. 2010;122(20): 2009-15.
28. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M, et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals (vol 10, pg 15, 2008). Europace. 2008;10(3): 386.
29. Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J. 2009;30(9):1113-20.
30. Conen D, Tedrow UB, Cook NR, Buring JE, Albert CM. Birth weight is a significant risk factor for incident atrial fibrillation. Circulation. 2010;122(8):764-70.
31. Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity-results of a metaanalysis. Am Heart J. 2008;155(2):310-5.
32. Everett BM, Conen D, Buring JE, Moorthy MV, Lee IM, Albert CM. Physical activity and the risk of incident atrial fibrillation in women. Circ-Cardiovasc Qual. 2011;4(3):321-7.
33. Healey JS, Connolly SJ. Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target. Am J Cardiol. 2003;91(10):9G-14G. (Pubitemid 36638516)
34. Shibata Y, Watanabe T, Osaka D, Abe S, Inoue S, Tokairin Y, et al. Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata Study. Int J Med Sci. 2011;8(7):514-22.
35. Buch P, Friberg J, Scharling H, Lange P, Prescott E. Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study. Eur Respir J. 2003;21(6):1012-6. (Pubitemid 36675619)
36. Rienstra M, Sun JX, Lubitz SA, Frankel DS, Vasan RS, Levy D, et al. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study. Am Heart J. 2012;163(1):119-24.
37. Fontes JD, Lyass A, Massaro JM, Rienstra M, Dallmeier D, Schnabel RB, et al. Insulin resistance and atrial fibrillation (from the Framingham Heart Study). Am J Cardiol. 2012;109(1):87-90.
38. Huxley RR, Alonso A, Lopez FL, Filion KB, Agarwal SK, Loehr LR, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart. 2012;98(2):133-8.
39. Smith JG, Newton-Cheh C, Almgren P, Struck J, Morgenthaler NG, Bergmann A, et al. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation. J Am Coll Cardiol. 2010;56(21):1713-9.
40. Schnabel RB, Larson MG, Yamamoto JF, Sullivan LM, Pencina MJ, Meigs JB, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation. 2010;121(2):200-7.
41. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006-10. (Pubitemid 37553570)
42. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110(4):364-7. (Pubitemid 38993843)
43. Needleman M, Calkins H. The role of obesity and sleep apnea in atrial fibrillation. Curr Opin Cardiol. 2011;26(1):40-5.
44. Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AMS, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. Brit Med J. 2012;345.